Trials / Completed
CompletedNCT00323817
To Evaluate the Efficacy and Safety in Subjects With Functional Dyspepsia
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 282 (estimated)
- Sponsor
- Zeria Pharmaceutical · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy and safety of Z-338 in subjects with Functional Dyspepsia
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Z-338 |
Timeline
- Start date
- 2006-04-01
- Primary completion
- 2009-04-01
- Completion
- 2009-10-01
- First posted
- 2006-05-10
- Last updated
- 2015-05-28
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT00323817. Inclusion in this directory is not an endorsement.